SBX — SynBiotic SE Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- €14.35m
- €15.66m
- €3.86m
Annual cashflow statement for SynBiotic SE, fiscal year end - December 31st, millions except per share.
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | — | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Preliminary | Final | Final | Final | Final |
| Net Income/Starting Line | — | -0.88 | -13.1 | -26 | -11.7 |
| Depreciation | |||||
| Non-Cash Items | — | 0.018 | 0.279 | 0.55 | 3.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | — | -0.52 | -0.668 | -0.06 | 1.06 |
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | — | -1.26 | -5.14 | -7 | -2.92 |
| Capital Expenditures | — | -2.14 | -0.366 | -0.478 | -0.019 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | 1.01 | -2.69 | 0.41 | -0.714 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | -1.13 | -3.06 | -0.068 | -0.733 |
| Financing Cash Flow Items | — | — | -0.047 | -0.156 | -0.154 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | 8.37 | 5.42 | 4.83 | 2.78 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | — | 5.98 | -2.79 | -2.24 | -0.877 |